Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2013 | 2 |
2014 | 2 |
2017 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells.
Immunol Cell Biol. 2017 Aug;95(7):620-629. doi: 10.1038/icb.2017.21. Epub 2017 Mar 30.
Immunol Cell Biol. 2017.
PMID: 28356569
Free PMC article.
Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells.
Davey MS, Morgan MP, Liuzzi AR, Tyler CJ, Khan MWA, Szakmany T, Hall JE, Moser B, Eberl M.
Davey MS, et al.
J Immunol. 2014 Oct 1;193(7):3704-3716. doi: 10.4049/jimmunol.1401018. Epub 2014 Aug 27.
J Immunol. 2014.
PMID: 25165152
Free PMC article.
Clinical Trial.
Item in Clipboard
Expanded Human Blood-Derived γδT Cells Display Potent Antigen-Presentation Functions.
Khan MW, Curbishley SM, Chen HC, Thomas AD, Pircher H, Mavilio D, Steven NM, Eberl M, Moser B.
Khan MW, et al.
Front Immunol. 2014 Jul 23;5:344. doi: 10.3389/fimmu.2014.00344. eCollection 2014.
Front Immunol. 2014.
PMID: 25101086
Free PMC article.
Item in Clipboard
Suppression of pro-inflammatory T-cell responses by human mesothelial cells.
Lin CY, Kift-Morgan A, Moser B, Topley N, Eberl M.
Lin CY, et al.
Nephrol Dial Transplant. 2013 Jul;28(7):1743-50. doi: 10.1093/ndt/gfs612. Epub 2013 Jan 25.
Nephrol Dial Transplant. 2013.
PMID: 23355626
Item in Clipboard
Tumor-killing γδ-TCRs take center stage.
Moser B.
Moser B.
Blood. 2012 Dec 20;120(26):5093-4. doi: 10.1182/blood-2012-10-460378.
Blood. 2012.
PMID: 23258897
Free article.
No abstract available.
Item in Clipboard
Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial.
Welton JL, Morgan MP, Martí S, Stone MD, Moser B, Sewell AK, Turton J, Eberl M.
Welton JL, et al.
J Bone Miner Res. 2013 Mar;28(3):464-71. doi: 10.1002/jbmr.1797.
J Bone Miner Res. 2013.
PMID: 23074158
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite